Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 8

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 8
---
 subsection (vii), according to which for every $1,000,000 raised by the Company through financing,
Mr. La Rosa shall be granted an equity award equal to 2% of the outstanding shares of common stock of the Company.

February 2025 Financing and June 2025 Exchange Agreement

On February 4, 2025 (the “Closing Date”),
we entered into a securities purchase agreement (the “SPA”) with an institutional investor (“2025 Investor”)
pursuant to which we agreed to issue and sell to 2025 Investor, upon the terms and conditions set forth in the SPA: (i) a Senior Secured
Convertible Note in the original principal amount of $5,500,000 which matures on the two-year anniversary of the Closing Date (the “Initial
Note”); and (ii) sixteen (16) warrants (“Incremental Warrants”), each to purchase additional Notes in an original principal
amount up to $2,500,000 at an exercise price of $2,256,250, in substantially the same form as the Initial Note (“Incremental Notes”
and together with the Initial Note, the “Notes”). The Incremental Warrants and Initial Note were issued to 2025 Investor
on the Closing Date. The purchase price paid by 2025 Investor under the SPA for the Initial Note and Incremental Warrants was $4,963,750,
which was used by the Company to pay-off certain indebtedness, pay certain outstanding fees and expenses, acquisitions and general corporate
purposes. The Company also granted 2025 Investor registration rights in the shares of common stock issuable pursuant to the SPA and conversion
of the Notes. The Company Group also entered into a security agreement with 2025 Investor pursuant to which the Company Group granted
the 2025 Investor a security interest in certain property of the Company Group to secure the Company’s obligations under the Notes.
The Company also agreed to obtain stockholder approval for the issuance of more than 19.99% of the issued and outstanding common stock
in this financing.

On February 4, 2025, as required by the SPA,
Joseph La Rosa, as the majority stockholder of the Company, approved (i) the issuance of the Initial Note, the Incremental Warrants and
Incremental Notes, all Interest Shares and all of the Conversion Shares and Incremental Conversion Shares in excess of 19.99% (without
regard to any limitation on conversion or exercise thereof) of